Dr Reddy's to Conduct Phase 3 Trials of Russia's COVID Vaccine
Hyderabad-based pharma, Dr Reddy's, has signed an agreement with Russian Direct Investment Firm to conduct phase 3 trials of Sputnik V vaccine in India. According to the deal, Dr Reddy's will receive 100 million doses of the vaccine, which is expected to be available by the end of the year if the trials are successful. Last month, Russia had cleared the Sputnik V vaccine for public use.
Tags: Coronavirus Vaccines, Russia, Sputnik-V, Dr Reddy's
Courtesy: Livemint
Hyderabad-based Dr Reddy's Laboratories Launch Arthritis Medicine in US
Hyderabad-based Reddy's Laboratories launched it's Over-The-Counter (OTC) Diclofenac sodium gel in US markets on September 9. The gel is used for temporary relief from arthritis pain in hand, wrist, elbow, knee and other areas. The company collaborated with Encube Ethicals in launching the product. North America Generics CEO Marc Kikuchi said, "The launch represents our continued commitment to the private label OTC space".
Tags: Arthritis, medicine, Dr Reddy's, United States
Courtesy: Deccan Herald